Edwards Lifesciences Up 24.8% Since SmarTrend Uptrend Call (EW)
Comtex SmarTrend(R) - Mon Dec 22, 5:21PM CST
SmarTrend identified an Uptrend for Edwards Lifesciences (NYSE:EW) on October 23rd, 2014 at $106.15. In approximately 2 months, Edwards Lifesciences has returned 24.79% as of today's recent price of $132.47.
EW: 130.75 (+1.17)
Intuitive Surgical's da Vinci System Strong, Cost Woes Linger - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 1:10PM CST
On Dec 18, we issued an updated research report on Intuitive Surgical, Inc. (ISRG). We remain optimistic about the new da Vinci Xi surgical system, which has received both the FDA approval and CE Mark
ISRG: 530.94 (+4.78), ETRM: 1.40 (-0.01), INGN: 29.99 (-0.09), EW: 130.75 (+1.17)
Will Walgreens (WAG) Surprise Earnings Estimates in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 8:10AM CST
Management at Walgreens (WAG) expects to continue to drive sales and margin growth on the front-end, offering the best standards in customer loyalty and customer care, with focus on integrating health, beauty and convenience.
ABC: 91.60 (+0.18), WMGI: 26.65 (-0.02), EW: 130.75 (+1.17), WAG: 76.67 (+0.16)
The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?
Todd Campbell, The Motley Fool - Motley Fool - Fri Dec 19, 6:44AM CST
From Medicaid expansion to cancer drugs to minimally invasive treatment for heart disease, Industry Focus looks at the 10 top performers among large-cap healthcare stocks in 2014. There were some surprises on the list this year, with strong showings...
AGN: 210.12 (+0.95), MDVN: 99.23 (+1.23), CNC: 105.96 (+1.03), JNJ: 104.59 (+0.31), VRX: 140.33 (-0.22), ACT: 254.20 (-1.68), EW: 130.75 (+1.17), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07)
Masimo's Multigas Monitoring Module Gets 510(k), CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 4:55PM CST
Masimo Corporation's (MASI) ISA OR+ multigas monitoring is a Masimo Open Connect (MOC-9) Module for the Root patient monitoring and connectivity platform.
MASI: 26.60 (+0.04), GMED: 24.37 (+0.44), COV: 103.35 (+0.57), EW: 130.75 (+1.17)
Volcano Agrees for Sellout to Philips to Aid Global Expansion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 1:40PM CST
Volcano Corporation (VOLC) recently entered into a definitive merger agreement with the Netherlands-based electronics major Royal Philips (PHG).
PHG: 29.39 (-0.06), VOLC: 17.95 (+0.02), EW: 130.75 (+1.17), IDXX: 148.68 (+1.45)
3 U.S. Medical Devices Stocks That Surged in 2014 - Analyst Blog
Swarup Gupta - Zacks Investment Research - Wed Dec 17, 9:20AM CST
The prospects of the medical devices industry have improved following a Republican victory in the midterm elections.
AGN: 210.12 (+0.95), ABT: 45.70 (-0.02), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), CAH: 82.07 (+0.15), CFN: 59.18 (+0.04), EW: 130.75 (+1.17), SWM: 41.49 (-0.44)
Jim Cramer: These Charts Prove It's Oil-and-Gas vs. Everything Else
at The Street - Tue Dec 16, 10:01AM CST
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
CAH: 82.07 (+0.15), WMT: 86.43 (-0.23), PDCO: 48.79 (-0.02), JACK: 78.82 (-0.17), CFR: 70.74 (+0.17), RCL: 82.36 (+0.16), TGT: 74.65 (-0.04), LOW: 67.51 (-0.43), MSFT: 48.14 (-0.31), HSIC: 137.87 (+0.15), REGN: 400.12 (+6.07), YUM: 72.79 (+0.11), SYK: 96.00 (-0.61), MU: 34.91 (-0.06), BCR: 169.10 (-0.44), MCK: 209.79 (+0.58), STX: 68.82 (+0.17), EW: 130.75 (+1.17), WLP: 128.71 (+0.94), UAL: 64.93 (+2.45), CELG: 109.60 (+3.48), CBRL: 138.16 (+0.46), AZO: 617.43 (-3.87), STE: 66.76 (+0.85), MRK: 57.46 (+0.25), MCD: 93.83 (-0.39), SHW: 264.55 (+1.46), BIIB: 340.89 (+5.13), BDX: 139.90 (+1.44), BMRN: 88.18 (+0.89), CCL: 45.39 (+0.09), MDT: 74.08 (+0.31), SNA: 139.09 (unch), JBLU: 15.50 (+0.21), ADBE: 74.74 (+0.36), HUM: 144.38 (-0.31), RFMD: 16.59 (+0.29), EBAY: 57.10 (-0.12), DPZ: 95.39 (-0.23), SRCL: 133.27 (-0.16), XLF: 24.95 (-0.04), ZMH: 114.11 (+0.64), CY: 14.61 (+0.26), HD: 103.56 (-0.20), ORLY: 193.95 (-1.11), DIS: 94.42 (-0.27), LLY: 70.16 (+0.42), BMY: 59.15 (-0.01), WDC: 113.11 (-0.18), PLKI: 55.50 (+0.01), HPQ: 40.54 (+0.18), FRGI: 56.97 (+0.47), DIN: 101.87 (-0.40), DRI: 58.42 (-0.09), CI: 104.23 (-0.08), ABC: 91.60 (+0.18), TJX: 67.87 (-0.25), JWN: 78.14 (-0.58), AVGO: 100.72 (-0.06)
Strength Seen in Opko Health (OPK): Stock Rises 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 8:25AM CST
Opko Health (OPK) was a big mover last session, with shares rising over 8% on the day.
ETRM: 1.40 (-0.01), FLDM: 32.31 (+0.30), OPK: 9.63 (+0.21), EW: 130.75 (+1.17)
Today In SA PRO: Monday, December 15
SA PRO Top Ideas - at Seeking Alpha - Tue Dec 16, 4:00AM CST
Top Idea: Vector Group by Alpha Gen Capital: Long / Mid-Cap / Cigarettes / Deep Value / Hidden Asset / Sum Of The Parts / Underfollowed / 70% Upside Top Idea: Rand Worldwide by Implied Value: Long / Micro-Cap / Application Software / Value /...
ABTL: 11.24 (-0.04), LGF: 32.36 (+0.49), EW: 130.75 (+1.17), LE: 54.28 (-0.30), VGR: 21.38 (+0.02)
3 Stocks To Buy in a Market Crash
Todd Campbell, The Motley Fool - Motley Fool - Mon Dec 15, 2:04PM CST
The stock market has gotten a bit more finicky over the past week, and that begs the question of whether or not investors could be in for a rocky start to 2015. If so, investors should be putting together their plans for handling a market drop now,...
JNJ: 104.59 (+0.31), EW: 130.75 (+1.17), CELG: 109.60 (+3.48)
Edwards Lifesciences Has Returned 20.9% Since SmarTrend Recommendation (EW)
Comtex SmarTrend(R) - Mon Dec 15, 11:17AM CST
SmarTrend identified an Uptrend for Edwards Lifesciences (NYSE:EW) on October 23rd, 2014 at $106.15. In approximately 2 months, Edwards Lifesciences has returned 20.88% as of today's recent price of $128.32.
EW: 130.75 (+1.17)
Synergetics USA (SURG) Jumps: Stock Adds 9.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 7:30AM CST
Synergetics USA, Inc. (SURG) was a big mover last session, as the company saw its shares rise over 9% on the day.
ETRM: 1.40 (-0.01), FLDM: 32.31 (+0.30), EW: 130.75 (+1.17), SURG: 4.39 (-0.03)
Announcing This Week's Outstanding Performance Award Winners - Chris Katje And DoctoRx
SA Editor Daniel Shvartsman - at Seeking Alpha - Mon Dec 15, 4:00AM CST
Dear readers, This week's Outstanding Performance award winners involve better known stocks than we sometimes cover in these awards. One winner saw a long-time SA author get ahead of a game-changing new 'product' before the rest of the market...
LGF: 32.36 (+0.49), EW: 130.75 (+1.17)
Top Healthcare Stocks for 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun Dec 14, 10:03AM CST
Source: Flickr user Tax Credits . This past year has been a great one for healthcare investors -- the S&P healthcare index ETF offered double the return of the S&P 500. Biotechnology stocks dominated the list of the 10 top-performing...
MNK: 97.84 (-0.29), MDVN: 99.23 (+1.23), CNC: 105.96 (+1.03), AGN: 210.12 (+0.95), VRTX: 115.15 (+1.40), ALNY: 93.52 (+0.97), EW: 130.75 (+1.17), ILMN: 186.22 (+2.72), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07), PBYI: 189.96 (+0.12)
Why the Earnings Streak Will Continue for Edwards Lifesciences (EW) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 7:34AM CST
Edwards Lifesciences has seen a nice streak of beating earnings estimates at the previous two reports, suggesting it has a nice short-term history of crushing expectations and that it could be a great candidate for another beat.
EW: 130.75 (+1.17)
Varian (VAR) Now a Strong Sell on Challenging Q1 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 12:40PM CST
On Dec 11, 2014, Zacks Investment Research downgraded Varian Medical Systems (VAR) to a Zacks Rank #5 (Strong Sell).
ETRM: 1.40 (-0.01), VAR: 88.44 (+0.69), EW: 130.75 (+1.17), ARAY: 7.54 (+0.19)
Novadaq Technologies Inc. (NVDQ) in Focus: Stock Soars 17.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 8:21AM CST
Novadaq Technologies Inc. (NVDQ) was a big mover last session, as the company saw its shares rise by over 17% on the day.
ETRM: 1.40 (-0.01), FLDM: 32.31 (+0.30), EW: 130.75 (+1.17), NVDQ: 16.90 (+0.55)
Health Care Equipment and Supplies Equities Scrutiny - Abbott Laboratories, Zimmer Holdings, Varian Medical Systems, Edwards Lifesciences, and Cerus
PR Newswire - Thu Dec 11, 7:55AM CST
Investor-Edge has initiated coverage on the following equities: Abbott Laboratories (NYSE: ABT), Zimmer Holdings Inc. (NYSE: ZMH), Varian Medical Systems Inc. (NYSE: VAR), Edwards Lifesciences Corporation (NYSE: EW), and Cerus Corporation (NASDAQ: CERS). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, December 10, 2014, ended on a negative note as the Dow Jones Industrial Average finished at 17,533.15, down 1.51% and the NASDAQ Composite closed at 4,684.03, down 1.73%. The S&P 500 finished the session 1.64% lower at 2,026.14. During the trading session, all the ten sectors finished on a lower note. The S&P 500 Health Care Sector Index ended the day at 803.98, down 1.59%, whereas the index has advanced 8.03% in the previous three months. Register for your complimentary reports on these five stocks at:
CERS: 6.49 (+0.29), ZMH: 114.11 (+0.64), ABT: 45.70 (-0.02), VAR: 88.44 (+0.69), EW: 130.75 (+1.17)
Cyberonics Posts Positive Epilepsy Device Data, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 1:30PM CST
Cyberonics' (CYBX) AspireSR generator delivers programmed VNS therapy, along with the benefits of a new feature ??? Automatic Stimulation ??? which identifies seizures.
ETRM: 1.40 (-0.01), FLDM: 32.31 (+0.30), EW: 130.75 (+1.17), CYBX: 54.63 (+0.48)